Daiichi Sankyo ProPharma

Daiichi Sankyo ProPharma is the primary manufacturing and supply chain subsidiary of the Daiichi Sankyo Group. Headquartered in Tokyo, the company manages multiple production facilities across Japan that specialize in the manufacture of active pharmaceutical ingredients (APIs) and finished drug products. The company is a leader in the production of complex modalities, including antibody-drug conjugates (ADCs), which are central to the parent company's oncology portfolio. Its capabilities span from small molecule synthesis to advanced biotechnological processes and high-potency drug manufacturing. Daiichi Sankyo ProPharma provides critical support for both clinical trial supplies and large-scale commercial production for global markets. By maintaining rigorous quality standards and a stable supply chain, the company plays a vital role in delivering innovative therapies to patients worldwide.